| CLF065 for Chronic Pouchitis (NCT07226050) | Calibr, a division of Scripps Research | 2026-06-01 |
| A Study to Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases (NCT06913608) | Calibr, a division of Scripps Research | 2026-03-01 |
| Long Term Follow-up Study for Subjects Administered CLBR001 (NCT06882317) | Calibr, a division of Scripps Research | 2025-08-28 |
| A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer (NCT06878248) | Calibr, a division of Scripps Research | 2025-04-17 |
| Study to Assess CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis (NCT06589219) | Calibr, a division of Scripps Research | 2024-08-19 |
| Study to Assess PDM608 in Healthy Adult Subjects (NCT05950906) | Calibr, a division of Scripps Research | 2023-06-27 |
| Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T (NCT04488354) | Calibr, a division of Scripps Research | 2021-01-21 |
| CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies (NCT04450069) | Calibr, a division of Scripps Research | 2020-08-14 |
| A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 in Subjects With Knee Osteoarthritis (NCT03133676) | Calibr, a division of Scripps Research | 2018-05-02 |